Leaflet NEXODAL 0.4mg / ml solution for injection / infusion

Product code:
W53068001
Quantity:
10
Indicated for:
reversal of opioid effects
Route of administration:
injectable / infusion
Substance:
naloxone (opioid antagonist)
ATC
V03AB15 — Various | All other therapeutic products | All other therapeutic products | Antidotes
Naloxone is a medication used to counteract the effects of opioid overdose, including severe respiratory depression. It acts as an opioid receptor antagonist, blocking the effects of opioids on the central nervous system.

The medication is administered intravenously, intramuscularly, or subcutaneously, and its effects are rapid, usually within minutes. It is used in emergency situations to save lives in cases of opioid overdose.

Side effects may include nausea, vomiting, excessive sweating, and, in rare cases, allergic reactions. In opioid-dependent patients, it may induce withdrawal symptoms.

Consult your doctor for more information about the use of Naloxone. It is essential to have access to this medication in emergency situations if you are at risk of opioid overdose.

General data about NEXODAL 0.4mg / ml

Substance:
naloxone
Date of latest medicines list:
01-03-2026
Product code:
W53068001
Concentration:
0.4mg / ml
Pharmaceutical form:
solution for injection / infusion
Packing volume:
1ml
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
HIKMA S.P.A. - ITALIA
Holder:
ORPHA-DEVEL HANDELS UND VERTRIEBS GMBH - AUSTRIA
Number:
6064/2014/01
Shelf life:
3 years-after packing for marketing;after the first opening-it is used immediately

Concentrations available for naloxone

  • 0.4mg/ml
  • 1.8mg

Combinations with other substances